is a drug
development company that sources late-stage discovery projects from
academia and spin-out companies, conducts early proof-of-principle
clinical studies and subsequently out-licenses the resulting programs
to the pharmaceutical and biotechnology industries.
Modern Biosciences wins £2.4 million award from UK Government’s Biomedical Catalyst